Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593686 | SCV000709430 | uncertain significance | not provided | 2017-06-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002636 | SCV001160619 | uncertain significance | not specified | 2019-06-19 | criteria provided, single submitter | clinical testing | The CEP290 c.916G>A; p.Val306Ile variant (rs558949569), to our knowledge, is not reported in the medical literature or gene-specific databases. The variant is listed in the ClinVar database (Variation ID: 502622) and in the general population with an allele frequency of 0.0036% (6/182620 alleles) in the Genome Aggregation Database. The amino acid at this position is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Due to limited information, the clinical significance of the variant is uncertain at this time. |
Fulgent Genetics, |
RCV002483661 | SCV002788047 | uncertain significance | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834911 | SCV002094344 | uncertain significance | Leber congenital amaurosis | 2019-10-28 | no assertion criteria provided | clinical testing |